Pericles Calias
2019
In 2019, Pericles Calias earned a total compensation of $1.3M as Former Chief Scientific Officer at Avalo Therapeutics, a 283% increase compared to previous year.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Option Awards | $657,095 |
| Salary | $324,167 |
| Stock Awards | $224,100 |
| Total | $1,345,362 |
Calias received $657.1K in option awards, accounting for 49% of the total pay in 2019.
Calias also received $140K in bonus, $324.2K in salary and $224.1K in stock awards.
Rankings
In 2019, Pericles Calias' compensation ranked 7,871st out of 13,971 executives tracked by ExecPay. In other words, Calias earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,871 out of 13,971 | 44th |
Division Manufacturing | 3,096 out of 5,695 | 46th |
Major group Chemicals And Allied Products | 1,168 out of 2,194 | 47th |
Industry group Drugs | 998 out of 1,880 | 47th |
Industry Pharmaceutical Preparations | 740 out of 1,392 | 47th |
Source: SEC filing on April 28, 2020.
Calias' colleagues
We found three more compensation records of executives who worked with Pericles Calias at Avalo Therapeutics in 2019.